Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | WHR | BHVN |
|---|---|---|
| Price | $30.03 | $12.97 |
| Change today | ▼ 0.92% | ▲ 0.78% |
| Market cap | $1.96B | $1.96B |
| Return, 3 months | -19.1% | -16.6% |
| Return, year to date | -57.8% | +14.9% |
| Return, 1 year | -61.1% | -18.3% |
| P/E (TTM) | 9.9 | -2.9 |
| P/B | 0.5 | 160.1 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 8.99% | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +33.7% | +61.9% |
| Analyst buy share | 0% | 70% |
| RSI (14) | 27 | 44 |
| 30-day volatility | 38.1% | 93.7% |
| Max drawdown, 1 year | -67.2% | -57.0% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
